Dimethylthioarsenicals as arsenic metabolites and their chemical preparations

Chemical Research in Toxicology

Volumn 17, Issue 7, 2004, Pages 914-921

  Suzuki, Kazuo T ^a   Mandal, Badal K ^a,b   Katagiri, Akio ^a   Sakuma, Yoko ^a   Kawakami, Ayumi ^a   Ogra, Yasumitsu ^a   Yamaguchi, Kentaro ^a   Sei, Yoshihisa ^a   Yamanaka, Kenzo ^c   Anzai, Kazunori ^b   Ohmichi, Masayoshi ^d   Takayama, Hiromitsu ^a   Aimi, Noriro ^a  

^a CHIBA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^c NIHON UNIVERSITY   (Japan)

^d Chiba City Institute of Public Health and Environmental Sciences   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; ARSENIC DERIVATIVE; CACODYLIC ACID; DIMETHYLTHIOARSINOUS ACID; DISULFITE; HYDROGEN SULFIDE; METHANEARSONIC ACID; SODIUM SULFIDE; SULFURIC ACID; THIOSULFATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC EMISSION SPECTROMETRY; CONTROLLED STUDY; DRUG METABOLISM; ELECTROSPRAY MASS SPECTROMETRY; GEL FILTRATION CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; LIVER METABOLISM; MALE; MASS SPECTROMETRY; NONHUMAN; OXIDATION; PORTAL VEIN; RAT; REDUCTION; SUPERNATANT;

ANIMALS; ARSENICALS; BIOTRANSFORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; LIVER; MALE; OXIDATION-REDUCTION; RATS; RATS, WISTAR; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

ANIMALIA;

EID: 3242686024     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx049963s     Document Type: Article

References (35)

1. Mandal, B. K., and Suzuki, K. T. (2002) Arsenic round the world: a review. Talanta 58, 201-235.
2. IARC (International Agency for Research on Cancer) (1980) IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man, Vol. 23, Some Metals and Metallic Compounds, World Health Organization, Lyon, France
3. Smith, A. H., Hopenhayn-Rich, C., Bates, M. N., Goeden, H. M., Hertz-Picciotto, I., Duggan, H. M., Wood, R., Kosnett, M. J., and Smith, M. T. (1992) Cancer risks from arsenic in drinking water. Environ. Health Perspect. 97, 259-267.
4. Chen, C.-J., Chen, C. W., Wu, M.-M., and Kuo, T.-L. (1992) Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br. J. Cancer 66, 888-892.
5. Hopenhayn-Rich, C., Biggs, M. L., and Smith, A. H. (1998) Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba Argentina. Int. Epidemiol. Assoc. 27, 561-569.
6. Rossman, T. G. (2003) Mechanism of arsenic carcinogenesis: an integrated approach. Mutat. Res. 533, 37-65.
7. NRC (National Research Council) (2001) Arsenic in Drinking Water: 2001 Update, p 244, National Academy Press, Washington, DC.
8. United Nations Synthesis Report on Arsenic in Drinking Water (2001).
9. WHO (2001) Arsenic Compounds, Environmental Health Criteria 224, 2nd ed., p 187, World Health Organization, Geneva.
10. Suzuki, K. T., Tomita, T., Ogra, Y., and Ohmichi, M. (2003) Arsenic metabolism in hyperbilirubinemic rats: Distribution and excretion in relation to transformation. In Arsenic Exposure and Health Effects V (Chappell, W. R., Abernathy, C. O., Calderon, R. L., and Thomas, D. J., Eds.) pp 353-365, Elsevier, London,
11. Le, X. C., Lu, X., Ma, M., Cullen, W. R., Aposhian, H. V., and Zheng, B. (2000) Speciation of key arsenic metabolic intermediates in human urine. Anal. Chem. 72, 5172-5177.
12. Vahter, M. (2000) Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity. Toxicol. Lett. 112-113, 209-217.
13. Vahter, M. (1999) Methylation of inorganic arsenic in different mammalian species and population groups. Sci. Prog. 82, 69-88.
14. Vahter, M., Marafante, E., and Dencker, L. (1984) Metabolism of arsenobetaine in mice, rats and rabbits. Sci. Total Environ. 30, 197-211.
15. Vahter, M., and Marafante, E. (1983) Intracellular interaction and metabolic fate of arsenite and arsenate in mice and rabbits. Chem. Biol. Interact. 47, 29-44.
16. Buchet, J. P., and Lauwerys, R. (1987) Study of factors influencing the in vivo methylation of inorganic arsenic in rats. Toxicol. Appl. Pharmacol. 91, 65-74.
17. Buchet, J. P., Lauwerys, R., and Roels, H. (1980) Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man. Int. Arch. Occup. Environ. Health 48, 71-79.
18. Suzuki, K. T., Tomita, T., Ogra, Y., and Ohmichi, M. (2001) Glutathione-conjugated arsenics in the potential hepato-enteric circulation in rats. Chem. Res. Toxicol. 14, 1604-1611.
19. Kala, S. V., Neely, M. W., Kala, G., Prater, C. I., Atwood, D. W., Rice, J. S., and Lieberman, M. W. (2000) The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic. J. Biol. Chem. 275, 33404-33408.
20. Paulusma, C. C., Van Geer, M. A., Evers, R., Heijin, M., Ottenhoff, R., Borst, P., and Oude Elferink, R. P. J. (1999) Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. Biochem. J. 338, 393-401.
21. Suzuki, K. T., Katagiri, A., Sakuma, Y., Ogra, Y., and Ohmichi, M. (2004) Distributions and chemical forms of arsenic after intravenous administration of dimethylarsinic and monomethylarsonic acids to rats. Toxicol. Appl. Pharmacol. In press.
22. Csanaky, I., and Gregus, Z. (2002) Species variations in the biliary and urinary excretion of arsenate, arsenite and their metabolites. Comp. Biochem. Physiol. Part C 131, 355-365.
23. Kala, S. V., Kala, G., Prater, C. I., Sartorelli, A. C., and Lieberman, M. W. (2004) Formation and urinary excretion of arsenic triglutathione and methylarsenic diglutathione. Chem. Res. Toxicol. 17, 243-249.
24. Reay, P. F., and Asher, C. J. (1977) Preparation and purification of 74 As-labeled arsenate and arsenite for use in biological experiments. Anal. Biochem. 78, 557-560.
25. Mandal, B. K., Ogra, Y., and Suzuki, K. T. (2001) Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic affected areas in West Bengal, India. Chem. Res. Toxicol. 14, 371-378.
26. III) by red blood cells. Chem. Res. Toxicol. 14, 1446-1452.
27. Styblo, M., Serves, S. V., Cullen, W. R., and Thomas, D. J. (1997) Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols. Chem. Res. Toxicol. 10, 27-33.
28. Yoshida, K., Kuroda, K., Zhou, X., Inoue, Y., Date, Y., Wanibuchi, H., Fukushima, S., and Endo, G. (2003) Urinary sulfur-containing metabolite produced by intestinal bacteria following oral administration of dimethylarsinic acid to rats. Chem. Res. Toxicol. 16, 1124-1129.
29. Kuroda, K., Yoshida, K., Yoshimura, M., Endo, Y., Wanibuchi, H., Fukushima, S., and Endo, G. (2004) Microbial metabolite of dimethylarsinic acid is highly toxic and genotoxic. Toxicol. Appl. Pharmacol. In press.
30. Yamaguchi, K. (2003) Cold-spray ionization mass spectrometry: principle and applications. J. Mass Spectrom. 38, 473-490.
31. Yamanaka, K., Mizoi, M., Tachikawa, M., Hasegawa, A., Hoshino, M., and Okada, S. (2003) Oxidative DNA damage following exposure to dimethylarsinous iodide: the formation of cis-thymine glycol. Toxicol. Lett. 143, 145-153.
32. Li, W., Wanibuchi, H., Salim, E. I., Yamamoto, S., Yoshida, K., Endo, G., and Fukushima, S. (1998) Promotion of NCI-Black-Reiter male rat bladder carcinogenesis by dimethylarsinic acid an organic arsenic compound. Cancer Lett. 134, 29-36.
33. Yoshida, K., Inoue, Y., Kuroda, K., Chen, H., Wanibuchi, H., Fukushima, S., and Endo, G. (1998) Urinary excretion of arsenic metabolites after long-term oral administration of various arsenic compounds to rats. J. Toxicol. Environ. Health Part A 54, 179-192.
34. Yoshida, K., Kuroda, K., Inoue, Y., Chen, H., Date, Y., Wanibuchi, H., Fukushima, S., and Endo, G. (2001) Metabolism of Dimethylarsinic acid in Rats: production of unidentified metabolites in vivo. Appl. Organomet. Chem. 15, 539-547.
35. Kuroda, K., Yoshida, K., Yasukawa, A., Wanibuchi, H., Fukushima, S., and Endo G. (2001) Enteric bacteria may play a role in mammalian arsenic metabolism. Appl. Organomet. Chem. 15, 548-552.